Similar Papers

Paper Title
Journal
Date
Author
End treatment response and sustained viral response in hepatitis C virus genotype 3 among Pakistani population
Muhammad Amir ... Muhammad Asadullah Siddiqui
Annals of Saudi Medicine | VOL. 33
Muhammad Amir, et. al.Muhammad Amir ... Muhammad Asadullah Siddiqui
01 Nov 2013
Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C
Hari S Conjeevaram ... James E Everhart
Hepatology | VOL. 22
Hari S Conjeevaram, et. al.Hari S Conjeevaram ... James E Everhart
01 Oct 1995
Age and Total Ribavirin Dose are Independent Predictors of Relapse after Interferon Therapy in Chronic Hepatitis C Revealed by Data Mining Analysis
Masayuki Kurosaki ... Hiroshi Yatsuhashi
Antiviral Therapy | VOL. 17
Masayuki Kurosaki, et. al.Masayuki Kurosaki ... Hiroshi Yatsuhashi
01 Jan 2012
Predictive factors of a response to interferon therapy in chronic hepatitis C.
Hideyuki Nomura ... Hitoshi Tada
Journal of clinical gastroenterology | VOL. 23
Hideyuki Nomura, et. al.Hideyuki Nomura ... Hitoshi Tada
01 Oct 1996
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Revealing bias in feature importance through PLS-DA: A critical examination of machine learning applications in chronic liver disease.
Yoshiyasu Takefuji
Journal of hepatology | VOL. -
Yoshiyasu TakefujiYoshiyasu Takefuji
07 Feb 2025
Introducing the Breakthrough Beyond the Journal series.
Vlad Ratziu
Journal of hepatology | VOL. 82
Vlad RatziuVlad Ratziu
01 Feb 2025
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies.
Homie A Razavi ... Eli Zuckerman
Journal of hepatology | VOL. -
Homie A Razavi, et. al.Homie A Razavi ... Eli Zuckerman
01 Feb 2025
MICROB-PREDICT works on identifying microbiome-based predictors and mechanisms of decompensated liver cirrhosis & ACLF, and develop personalised treatment strategies. Discover the project!
-
Journal of Hepatology | VOL. 82
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.